{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:28:06Z","timestamp":1791070086927,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1053\/j.ajkd.2004.10.018","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T11:07:54Z","timestamp":1134472074000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15"],"prefix":"10.1053","volume":"45","author":[{"given":"Christoph","family":"Licht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annic","family":"Weyersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Heinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Stapenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Devenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Waldherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kirschfink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2004.10.018_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2004.10.018_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial haemolytic uremic syndrome","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ndt\/15.8.1112","article-title":"Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura\u2014New insights into underlying biochemical mechanisms","volume":"15","author":"Furlan","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2004.10.018_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene","volume":"40","author":"Neumann","year":"2003","journal-title":"J Med Genet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2004.10.018_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/302673","article-title":"Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome","volume":"65","author":"Ying","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(81)90107-1","article-title":"Double decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma","volume":"44","author":"Brandslund","year":"1981","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.ajkd.2004.10.018_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/79.1.65","article-title":"A study of optimal reaction conditions for an assay of the human alternative complement pathway","volume":"79","author":"Joiner","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib9","series-title":"Experimental Immunochemistry","first-page":"133","article-title":"Complement and complement fixation","author":"Mayer","year":"1961"},{"key":"10.1053\/j.ajkd.2004.10.018_bib10","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1074\/jbc.272.9.5627","article-title":"The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins","volume":"272","author":"Skerka","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2004.10.018_bib11","first-page":"251","article-title":"Attachement of the soluble complement regulator factor H to the cell and tissue surfaces","volume":"19","author":"Joszi","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(01)06339-5","article-title":"Complement factor H and the haemolytic uraemic syndrome","volume":"358","author":"Taylor","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4906(01)01972-X","article-title":"Hemolytic uremic syndrome","volume":"22","author":"Zipfel","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib14","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.4049\/jimmunol.155.12.5663","article-title":"Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1","volume":"155","author":"Kuhn","year":"1995","journal-title":"J Immunol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2004.10.018_bib16","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.4049\/jimmunol.169.9.4702","article-title":"Localization of the host recognition functions of complement factor H at the carboxyl-terminal","volume":"169","author":"Pangburn","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical haemolytic uremic syndrome","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1567-5769(00)00047-3","article-title":"Complement factor H and haemolytic uremic syndrome","volume":"1","author":"Zipfel","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1681\/ASN.V9122318","article-title":"Human complement factor H deficiency associated with hemolytic uremic syndrome","volume":"9","author":"Rougier","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s004670050069","article-title":"Factor H and the pathogenesis of renal diseases","volume":"14","author":"Ault","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib22","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9440(10)64481-1","article-title":"The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II","volume":"161","author":"Hegasy","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","article-title":"Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency","volume":"95","author":"Hogasen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2004.10.018_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.V102281","article-title":"Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","volume":"10","author":"Noris","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0161-5890(99)00101-7","article-title":"FHL-1\/reconectin and factor H","volume":"36","author":"Friese","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2004.10.018_bib29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00467-003-1192-3","article-title":"Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality","volume":"18","author":"Gerber","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s004670100609","article-title":"Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency","volume":"16","author":"Nathanson","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2004.10.018_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ndt\/17.4.684","article-title":"Successful treatment of factor H-related haemolytic uraemic syndrome","volume":"17","author":"Stratton","year":"2002","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860401457X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860401457X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:29:03Z","timestamp":1759454943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860401457X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S027263860401457X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.10.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2004.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}